Data Protection for Pharmaceutical & Life Sciences
Pharmaceutical companies handle patient data across clinical trials, pharmacovigilance systems, commercial operations, and research databases. IQWorks automates privacy compliance, protects trial participant data, and manages the complex data governance requirements of the life sciences industry.
The Challenge
Pharmaceutical and life sciences companies manage personal data across the entire drug development lifecycle. Clinical trials collect detailed patient health information, genetic data, and biomarker results. Pharmacovigilance systems track adverse event reports containing patient identifiers. Commercial operations maintain prescriber data, patient assistance program records, and marketing databases. Research collaborations share data with CROs, academic institutions, and regulatory agencies.
Pharma companies must comply with HIPAA for US patient data, GDPR for European trial participants, FDA 21 CFR Part 11 for electronic records, and ICH GCP guidelines for clinical trial data integrity. The intersection of health privacy, clinical research regulations, and commercial data governance creates one of the most complex compliance environments in any industry.
Cross-border data transfers are essential for global clinical trials but face increasing restrictions under GDPR, China's PIPL, and other national data protection laws. De-identification of clinical data for secondary research use requires careful application of statistical methods that preserve data utility while protecting participant privacy.
Clinical Trial Data Governance
Clinical trials generate sensitive patient data including health records, genetic information, and biomarker results across multiple sites and countries, each with different privacy requirements.
Cross-Border Data Transfer Complexity
Global clinical trials require transferring patient data across national borders. GDPR, PIPL, and other laws impose restrictions and documentation requirements on international data transfers.
Pharmacovigilance Data Privacy
Adverse event reporting contains patient identifiers that must be protected while enabling regulatory reporting obligations. Balancing privacy with patient safety reporting is a constant tension.
GxP and 21 CFR Part 11 Compliance
Electronic records containing patient data must meet FDA validation requirements for data integrity, audit trails, and electronic signatures while also satisfying privacy requirements.
The Solution
IQWorks provides pharmaceutical companies with data protection that spans the entire drug development lifecycle. DiscoverIQ scans clinical trial management systems, EDC platforms, pharmacovigilance databases, and commercial systems to map all patient and prescriber data. ClassifyIQ applies life sciences-specific classification that distinguishes between clinical data, genetic information, adverse event data, and commercial personal data.
ProtectIQ applies de-identification methods appropriate for clinical research, including HIPAA Safe Harbor and Expert Determination approaches, as well as pseudonymization techniques that support GDPR-compliant cross-border transfers. ComplyIQ manages compliance documentation across HIPAA, GDPR, FDA regulations, and ICH GCP guidelines.
SearchIQ automates data subject requests from trial participants, patients, and healthcare professionals across all connected systems. RetainIQ enforces retention schedules that account for regulatory requirements to retain clinical trial data for specific periods after study completion.
How It Works
Connect Life Sciences Systems
IQWorks integrates with CTMS, EDC platforms, safety databases, CRM systems, and research data repositories through life sciences-specific connectors.
Discover Patient and Clinical Data
DiscoverIQ identifies patient PII, genetic data, adverse event records, and prescriber information across clinical, safety, and commercial systems.
Apply Life Sciences Classification
ClassifyIQ categorizes data by type (clinical, genetic, safety, commercial) and applicable regulation (HIPAA, GDPR, 21 CFR Part 11, ICH GCP).
De-identify for Research Use
ProtectIQ applies validated de-identification methods for clinical data sharing, secondary research, and cross-border transfers while maintaining data utility.
Manage Cross-Border Compliance
ComplyIQ tracks data transfer mechanisms, maintains Transfer Impact Assessments, and ensures documentation is current for all international data flows.
Key Benefits
Recommended Products
Frequently Asked Questions
Does IQWorks integrate with clinical trial management systems?
Yes. IQWorks provides connectors for major CTMS and EDC platforms including Medidata Rave, Oracle Clinical, Veeva Vault, and others used in pharmaceutical research.
How does IQWorks handle de-identification of clinical trial data?
ProtectIQ supports HIPAA Safe Harbor and Expert Determination de-identification methods, as well as GDPR-compliant pseudonymization. The platform validates de-identification quality and maintains audit trails for regulatory submission.
Can IQWorks manage cross-border data transfers for global trials?
Yes. ComplyIQ tracks the legal basis for each cross-border transfer, maintains Transfer Impact Assessments, and monitors regulatory changes that may affect transfer mechanisms such as Standard Contractual Clauses.